Marketaxess Holdings
MKTX · NASDAQ
About MKTX
- Employees
- 868
- Headquarters
- New York City, New York
- Listed
- Nov 5, 2004
- Sector
- Financials
- Industry
- Capital Markets
- Website
- marketaxess.com
MKTX key statistics
- Market cap
- 5.79B
- Price-earnings ratio
- 24.78
- Dividend yield
- 1.96%
- Average volume
- 729.33K
- Volume
- 846.07K
- Open price
- $164.53
- High today
- $164.61
- Low today
- $164.41
- 52 Week high
- $195.97
- 52 Week low
- $108.75
Marketaxess Holdings (MKTX) at a glance
As of Oct 20, 2026, Marketaxess Holdings (MKTX) shares are priced at $164.49, giving the company a market cap of 5.79B, a price-to-earnings ratio of 24.78 and a dividend yield of 1.96%.
Today the stock has traded between $164.41 and $164.61. The current price is 0.1% above the day's low and 0.1% below its high.
Volume so far is 846.07K shares, in line with the average of 729.33K shares a day.
Over the past year Marketaxess Holdings has ranged from $108.75 to $195.97, and now sits 64% of the way up that range.
Marketaxess Holdings met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $1.95 per share against an estimate of $1.89.
The average analyst price target is $172.71, 5.0% above the current price, from 10 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold100.0%
- Sell0.0%
- Low
- $125.24
- Now
- $164.49
- High
- $263.78
MKTX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 8.1% on average.
- Q3 FY24: reported $1.90 per share against an estimate of $1.88
- Q4 FY24: reported $1.73 per share against an estimate of $1.71
- Q1 FY25: reported $1.87 per share against an estimate of $1.85
- Q2 FY25: reported $2.00 per share against an estimate of $2.00
- Q3 FY25: reported $1.84 per share against an estimate of $1.73
- Q4 FY25: reported $2.51 per share against an estimate of $1.68
- Q1 FY26: reported $2.25 per share against an estimate of $2.20
- Q2 FY26: reported $1.95 per share against an estimate of $1.89
MKTX news
- Press releaseBusiness Wire
- Press releasePRNewswire
Are SAFT, LXFR, MKTX Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
MarketAxess Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of MarketAxess Holdings Inc. - MKTX
- Press releasePRNewswire
Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
MKTX Stock Alert: Halper Sadeh LLC is Investigating Whether MarketAxess Holdings Inc. is Obtaining a Fair Price for its Shareholders
- Press releasePRNewswire
Are PSNL, MKTX, BZH, HOWL Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
Are MKTX and CBZ Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?
Similar companies
Companies in the same industry as Marketaxess Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- WFFWF Holding$0.0929−3.83%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.